Perspective Therapeutics
CATX
35 hedge funds and large institutions have $3.7M invested in Perspective Therapeutics in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 8 closing their positions.
0.05% less ownership
Funds ownership: 1.18% → 1.13% (-0.05%)
19% less funds holding
Funds holding: 43 → 35 (-8)
29% less capital invested
Capital invested by funds: $5.19M → $3.7M (-$1.49M)
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WE
Wealth Effects
Boston,
Massachusetts
|
+$34.2K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$342 |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$48 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
-$170K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$21.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 5 |
VF
Virtu Financial
New York
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAI
26
Capital Advisors Inc
Tulsa,
Oklahoma
| $4K | – | – | – |
|
|
RJFSA
27
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $4K | – | – | – |
|
28
Ameriprise
Minneapolis,
Minnesota
| $3K | -$1.03K | -300 | -17% |
|
|
AAM
29
Auxier Asset Management
Aurora,
Oregon
| $3K | – | – | – |
|
|
GVAG
30
Great Valley Advisor Group
Wilmington,
Delaware
| $3K | – | – | – |
|
31
Wells Fargo
San Francisco,
California
| $1K | -$3 | -1 | -0.2% |
|
|
JFA
32
JNBA Financial Advisors
Bloomington,
Minnesota
| $1K | – | – | – |
|
|
TWC
33
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $540 | – | – | – |
|
|
AIA
34
Arcadia Investment Advisors
Eagle,
Idaho
| $51 | – | – | – |
|
|
VCM
35
Venator Capital Management
Toronto,
Ontario, Canada
| – | -$170K | -55,000 | Closed |
|
|
36
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11K | -3,533 | Closed |
|
|
TSS
37
Two Sigma Securities
New York
| – | -$10K | -3,173 | Closed |
|
|
VF
38
Virtu Financial
New York
| – | -$8K | -2,447 | Closed |
|
39
Jane Street
New York
| – | -$6K | -2,077 | Closed |
|
40
UBS Group
Zurich,
Switzerland
| – | -$5.74K | -1,678 | -96% |
|
CATX Hedge Fund Activity: Q3 2022 in Review
35 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2022, worth a combined $3.7M — down 29% from $5.19M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CATX and 0 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 3 added.
The largest buyer was Wealth Effects, adding an estimated $34.2K. The largest seller was Venator Capital Management, exiting entirely with an estimated $170K sold.
- 35 institutional investors held Perspective Therapeutics (CATX) as of Q3 2022, down from 43 in Q2 2022.
- Funds reported $3.7M of Perspective Therapeutics stock for Q3 2022, down 29% quarter-over-quarter.
- 0 funds opened new Perspective Therapeutics positions in Q3 2022 and 8 closed out, a net change of -8 holders.
- The largest Perspective Therapeutics buyer in Q3 2022 was Wealth Effects, an estimated $34.2K added.
- The largest Perspective Therapeutics seller in Q3 2022 was Venator Capital Management, an estimated $170K sold.
Based on aggregated 13F filings for Q3 2022.